S&P 500
(0.26%) 5 113.17 points
Dow Jones
(0.20%) 38 318 points
Nasdaq
(0.30%) 15 976 points
Oil
(-0.98%) $83.03
Gas
(4.94%) $2.02
Gold
(0.06%) $2 348.50
Silver
(0.24%) $27.60
Platinum
(4.15%) $960.35
USD/EUR
(-0.18%) $0.933
USD/NOK
(-0.28%) $10.99
USD/GBP
(-0.48%) $0.797
USD/RUB
(1.72%) $93.45

Realaus laiko atnaujinimai Stryker Corp [SYK]

Birža: NYSE Sektorius: Healthcare Pramonė: Medical - Devices
Upcoming Earnings Alert

Quarter results today
(amc 2024-04-29)

Expected move: +/- 2.26%

Atnaujinta29 bal. 2024 @ 19:00

1.18% $ 339.58

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 19:00):

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine...

Stats
Šios dienos apimtis 368 240
Vidutinė apimtis 1.27M
Rinkos kapitalizacija 129.13B
EPS $0 ( 2024-01-30 )
Kita pelno data ( $2.35 ) 2024-05-06
Last Dividend $0.750 ( 2023-09-28 )
Next Dividend $0 ( N/A )
P/E 41.11
ATR14 $0.264 (0.08%)
Insider Trading
Date Person Action Amount type
2024-03-21 Stiles Spencer S Buy 203 Common Stock
2024-03-21 Stiles Spencer S Sell 3 796 Common Stock
2024-03-21 Stiles Spencer S Sell 203 Dividend Equivalents
2024-03-21 Pierce James Andrew Buy 203 Common Stock
2024-03-21 Pierce James Andrew Sell 4 412 Common Stock
INSIDER POWER
-59.40
Last 100 transactions
Buy: 383 181 | Sell: 1 508 551

Tūris Koreliacija

Ilgas: -0.24 (neutral)
Trumpas: 0.29 (neutral)
Signal:(39.889) Neutral

Stryker Corp Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Stryker Corp Koreliacija - Valiuta/Žaliavos

The country flag -0.56
( weak negative )
The country flag -0.53
( weak negative )
The country flag 0.00
( neutral )
The country flag -0.18
( neutral )
The country flag 0.12
( neutral )
The country flag 0.42
( neutral )

Stryker Corp Finansinės ataskaitos

Annual 2023
Pajamos: $20.50B
Bruto pelnas: $13.06B (63.70 %)
EPS: $8.34
FY 2023
Pajamos: $20.50B
Bruto pelnas: $13.06B (63.70 %)
EPS: $8.34
FY 2022
Pajamos: $18.45B
Bruto pelnas: $11.58B (62.76 %)
EPS: $6.23
FY 2021
Pajamos: $17.11B
Bruto pelnas: $10.97B (64.11 %)
EPS: $5.31

Financial Reports:

No articles found.

Stryker Corp Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.695
(N/A)
$0.750
(N/A)
$0.750
(N/A)
$0.750
(N/A)
$0.750
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Stryker Corp Dividend Information - Dividend King

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.08 - Stable (21.67%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.00150 1991-12-24
Last Dividend $0.750 2023-09-28
Next Dividend $0 N/A
Payout Date 2023-10-31
Next Payout Date N/A
# dividends 75 --
Total Paid Out $25.16 --
Avg. Dividend % Per Year 0.67% --
Score 5.39 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 6.08
Div. Directional Score 9.57 --
Next Divdend (Est)
(2024-07-15)
$0.762 Estimate 19.19 %
Dividend Stability
0.51 Average
Dividend Score
5.39
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
1991 $0.00150 0.08%
1992 $0.00100 0.02%
1993 $0.00213 0.04%
1994 $0.00225 0.06%
1995 $0.00275 0.06%
1996 $0.00625 0.10%
1997 $0.0275 0.37%
1998 $0.00750 0.08%
1999 $0.0325 0.24%
2000 $0.0400 0.23%
2001 $0.0500 0.21%
2002 $0.0600 0.21%
2003 $0.0700 0.21%
2004 $0.0900 0.22%
2005 $0.110 0.23%
2006 $0.220 0.49%
2007 $0.330 0.60%
2008 $0.400 0.54%
2009 $0.250 0.61%
2010 $0.630 1.21%
2011 $0.753 1.38%
2012 $0.904 1.77%
2013 $1.100 1.97%
2014 $1.260 1.69%
2015 $1.415 1.51%
2016 $1.565 1.74%
2017 $1.745 1.46%
2018 $1.930 1.22%
2019 $2.14 1.38%
2020 $2.36 1.12%
2021 $2.59 1.08%
2022 $2.84 1.06%
2023 $2.25 0.92%
2024 $0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend Knight 2023-06-30 Quarterly 2 5.23% 8.53
PHK Dividend Royal 2023-11-10 Monthly 22 6.88% 8.50
JQC Dividend Royal 2023-11-14 Monthly 22 6.56% 8.50
PCF Dividend King 2023-12-18 Monthly 38 7.05% 8.50
PVL Dividend King 2023-11-15 Monthly 14 9.37% 8.50
NCV Dividend Royal 2024-02-09 Monthly 22 7.68% 8.50
SBR Dividend Royal 2023-11-14 Monthly 38 7.74% 8.50
MTR Dividend Diamond 2023-10-30 Monthly 39 10.10% 8.50
PDI Dividend Royal 2023-11-10 Monthly 13 7.86% 8.50
ZTR Dividend King 2024-02-09 Monthly 37 8.35% 8.50

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1541.5006.9110.00[0 - 0.5]
returnOnAssetsTTM0.07931.2007.368.83[0 - 0.3]
returnOnEquityTTM0.1791.5009.1210.00[0.1 - 1]
payoutRatioTTM0.360-1.0006.40-6.40[0 - 1]
currentRatioTTM1.5800.8007.105.68[1 - 3]
quickRatioTTM0.8610.8009.647.71[0.8 - 2.5]
cashRatioTTM0.3751.5009.0310.00[0.2 - 2]
debtRatioTTM0.326-1.5004.57-6.86[0 - 0.6]
interestCoverageTTM69.431.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM9.772.006.7410.00[0 - 30]
freeCashFlowPerShareTTM8.252.005.8710.00[0 - 20]
debtEquityRatioTTM0.699-1.5007.20-10.00[0 - 2.5]
grossProfitMarginTTM0.6371.0002.722.72[0.2 - 0.8]
operatingProfitMarginTTM0.1901.0008.218.21[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2861.0009.529.52[0.2 - 2]
assetTurnoverTTM0.5140.8009.917.93[0.5 - 2]
Total Score13.07

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM40.291.0006.030[1 - 100]
returnOnEquityTTM0.1792.509.4410.00[0.1 - 1.5]
freeCashFlowPerShareTTM8.252.007.2510.00[0 - 30]
dividendYielPercentageTTM0.9241.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM9.772.006.7410.00[0 - 30]
payoutRatioTTM0.3601.5006.40-6.40[0 - 1]
pegRatioTTM0.2231.500-1.8480[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1811.0007.970[0.1 - 0.5]
Total Score6.08

Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.